Enlightenment Research’s Chemed CHE Stock Holding History

Enlightenment Research’s Portfolio CHE Stock Details CHE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-300	Closed	-$85K	–	202
2018 Q4	$85K	Buy	+300	New	+$90.5K	0.11%	208

Other funds holding CHE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Enlightenment Research's CHE Position: Q1 2019 in Review

Enlightenment Research sold out of Chemed (CHE) in Q1 2019, closing a stake of 300 shares — an estimated $85K sold.

Enlightenment Research first reported a position in CHE in Q4 2018 and held it in 1 quarter. The position peaked at $85K in Q4 2018. 382 funds tracked by Wall St. Rank hold CHE as of Q1 2019.

Enlightenment Research reported no remaining Chemed position as of Q1 2019 after selling out during the quarter.
Enlightenment Research sold 300 Chemed shares in Q1 2019, an estimated $85K.
Enlightenment Research first reported a position in Chemed in Q4 2018 and held it in 1 quarter.
Enlightenment Research's Chemed position peaked at $85K in Q4 2018.
382 funds tracked by Wall St. Rank held Chemed as of Q1 2019.

Based on Enlightenment Research's 13F filing for Q1 2019, filed 3 May 2019.